← Leaderboards
Jing Wen
University Of California Los Angeles
$2,923,926
Attributed
$3,765,490
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,765,490 · 3
By mechanism
R01$3,385,173 · 2
R56$380,317 · 1
Top collaborators
- Nancy Logan Haigwood1 shared
- Ann Jones Hessell1 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Yuan Zhai$7,235,062
- Dennis J Hartigan-O'Connor$32,284,293
- Scott G Kitchen$17,099,191
- Theodoros Kelesidis$4,316,026
- Anjie Zhen$4,232,021
Others in their field
Other Emerging Leaders on “Nanocapsule”
- Matthew Charlton Good · University Of Pennsylvania$843,626
- Claire Clelland · University Of California, San Francisco$434,980
- Teng Su · Duke University$432,404
- Sean German · Electronic Biosciences, Inc.$349,996
- Gayle Boxx · Aukera, Inc.$299,979
- Samuel N Sanders · Quadratic 3d, Inc.$255,352
Research focus
NanocapsuleBrainMonoclonal AntibodiesTreatment EfficacyTechnologyNanoencapsulatedAntibody TherapySuccessAntibodiesBlood - Brain Barrier AnatomyNonhuman PrimateNanotechnologyThinnessCellsPolymersImmunotherapyBlood-Brain Barrier PenetrationEffective TherapyEncapsulatedCholine AnalogCerebrospinal FluidBindingDesignSurface
Grant awards (8)
Improved delivery of bNAbs for targeting CNS infection in infants$839,952
R01 · FY2025 · NS · contact PI
Improved delivery of bNAbs for targeting CNS infection in infants$843,177
R01 · FY2024 · NS · contact PI
Targeting delivery of mAbs to CNS metastases$281,781
R01 · FY2024 · CA · contact PI
Targeting delivery of mAbs to CNS metastases$349,713
R01 · FY2023 · CA · contact PI
An antioxidant enzyme to suppress hyperinflammation induced by SARS-CoV-2$380,317
R56 · FY2022 · AI · contact PI
Targeting delivery of mAbs to CNS metastases$356,850
R01 · FY2022 · CA · contact PI
Targeting delivery of mAbs to CNS metastases$356,850
R01 · FY2021 · CA · contact PI
Targeting delivery of mAbs to CNS metastases$356,850
R01 · FY2020 · CA · contact PI